Mercado de fabricación continua farmacéutica: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00008245
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 239
Buy Now

Se espera que el mercado de fabricación continua de productos farmacéuticos alcance los 3.064,38 millones de dólares en 2027, frente a los 1.459,53 millones de dólares de 2019. Se estima que el mercado crecerá a una tasa compuesta anual del 9,8 % de 2020 a 2027.

La fabricación continua en la industria farmacéutica es el resultado de los avances tecnológicos con respecto a las técnicas de producción. En los últimos años, en la industria farmacéutica se siguió el método tradicional de fabricación por lotes. Sin embargo, el desarrollo de la tecnología ha acelerado la producción en masa con una calidad mejorada y ha abordado muchos problemas primarios, como la retirada de medicamentos. La industria farmacéutica ha comenzado recientemente a reconocer la fabricación continua como una opción para mejorar y sostener las operaciones de fabricación.

regiones lucrativas para los mercados de fabricación continua farmacéutica


Perspectivas del mercado

Creciente escasez de medicamentos

La escasez de medicamentos y fármacos esenciales es cada vez más frecuente en todo el mundo. La creciente escasez está generando una carga para los sistemas de salud junto con costos adicionales y riesgos para los pacientes. salud. Los pacientes que necesitan medicamentos no reciben las dosis adecuadas debido a la falta de disponibilidad de medicamentos. Según la Información sobre Medicamentos de la OMS 2016, se ha informado de escasez de medicamentos esenciales en países de ingresos bajos, medios y altos. La escasez de medicamentos plantea riesgos para la salud del paciente como resultado de la falta de tratamiento, el tratamiento insuficiente y posibles errores de medicación al intentar sustituir los medicamentos faltantes.

La Administración de Alimentos y Medicamentos ( FDA) afirma que las razones de la escasez de medicamentos se producen por diversas razones, incluidos problemas de calidad, ineficiencia de fabricación, retrasos e interrupciones. Los medicamentos que a menudo escasean incluyen tratamientos inyectables estériles y oncológicos/contra el cáncer. El aviso de los fabricantes a la FDA sobre la escasez inminente o actual de medicamentos permite a la FDA trabajar con los fabricantes para encontrar soluciones viables, una de las cuales suele ser aumentar la fabricación de medicamentos mediante la implementación de sistemas nuevos y avanzados, como la fabricación continua. .

En 2018, la FDA de EE. UU. desarrolló un nuevo Grupo de Trabajo sobre Escasez de Medicamentos para explorar las razones y causas de la escasez de medicamentos. El Grupo de Trabajo analizó 163 medicamentos que escasearon entre 2013 y 2017. Además, una encuesta del Instituto de Prácticas Seguras de Medicamentos (ISMP) en 2017 reveló que la categoría de tratamiento estaba más comúnmente involucrada en la escasez de medicamentos.

El escenario de escasez de medicamentos también prevalece en los países europeos. Por ejemplo, según un informe publicado por The Economist Intelligence Unit Limited en 2017, la prevalencia de la escasez de medicamentos era alta en Europa. Las tres causas principales determinadas para la escasez incluyeron causas manufactureras, económicas y regulatorias. Por lo tanto, para satisfacer la creciente demanda de productos biológicos y medicamentos y frenar la falta de disponibilidad de medicamentos, el mercado de fabricación continua de productos farmacéuticos presenta un escenario de crecimiento prometedor.

Product-BasedInsights< /h3>

En 2019, el segmento de sistemas integrados representó la mayor cuota de mercado del mercado mundial de fabricación continua de productos farmacéuticos. Se espera que los sistemas integrados dominen el segmento de productos debido a su fácil disponibilidad y accesibilidad, así como a una mayor adopción de estos sistemas que los sistemas semicontinuos y los controles. Los sistemas integrados ayudan a construir un flujo continuo durante el proceso de fabricación, facilitan la integración de un extremo a otro y mejoran la utilización de los activos.

Mercado global de fabricación continua de productos farmacéuticos, por producto– 2019 y 2027


Información basada en aplicaciones

Según la aplicación, el mercado de fabricación continua farmacéutica está segmentado en la fabricación de productos finales y la fabricación de API. El segmento de fabricación de productos finales tuvo una mayor participación del mercado en 2019. Sin embargo, se estima que el segmento de fabricación de API registrará una CAGR más alta en el mercado durante el período de pronóstico. Aumento en el número de compañías farmacéuticas, avances tecnológicos en los sistemas de fabricación continua y aumento en la demanda de medicamentos farmacéuticos son factores clave para el crecimiento del mercado de fabricación de productos finales.

Información basada en el usuario final

Basada en el usuario final, El mercado de fabricación continua de productos farmacéuticos está segmentado en empresas de fabricación a gran escala y departamentos de I+D. El segmento de empresas de fabricación a gran escala tuvo una mayor participación del mercado en 2019. Además, se estima que el mismo segmento registrará una CAGR más alta en el mercado durante el período de pronóstico. Esto se atribuye a la creciente adopción de tecnologías continuas para abordar los desafíos relacionados a la calidad del producto, el suministro de medicamentos y los costos operativos.

Perspectivas estratégicas

Las asociaciones y adquisiciones son las estrategias más comúnmente adoptadas por las empresas para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Los actores del mercado suelen adoptar estas estrategias para ampliar su cartera de productos.

Por ejemplo, en mayo de 2019, Thermo Fisher Scientific adquirió una planta de fabricación de sustancias farmacéuticas en Cork, Irlanda, de GlaxoSmithKline para satisfacer demanda de los clientes para el desarrollo y la fabricación comercial de ingredientes farmacéuticos activos (API) complejos.

Mercado global de fabricación continua de productos farmacéuticos: Subproducto

  • Sistemas integrados
  • Sistemas semicontinuos
    • Granuladores continuos
    • Mezcladores continuos
    • Compresores continuosâ €¨
    • Recubridores continuos
    • Secadores continuos
    • Otros sistemas semicontinuos
  • Controles


Mercado global de fabricación continua de productos farmacéuticos: Por aplicación

  • Fabricación de producto final
    • Fabricación de dosis sólidas
    • Fabricación de dosis líquidas
  • API Fabricación


Mercado global de fabricación continua de productos farmacéuticos: Por usuario final

  • Empresas de fabricación a gran escala
    • Empresas farmacéuticas
    • Organizaciones de fabricación por contrato
  • Departamentos de I+D
    • Organizaciones de investigación por contrato
    • Institutos de investigación


Mercado de fabricación continua farmacéutica– Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
  • Asia Pacífico
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia< /li>
  • Medio Oriente y África
    • Sudáfrica
    • Arabia Saudita
    • EAU
  • América del Sur y Central
    • Brasil
    • Argentina

 

Perfiles de la empresa

  • Grupo GEA
  • Thermo Fisher Scientific, Inc.
  • Glatt GmbH
  • Munson Machinery Co., Inc.
  • Hosokawa Micron Group
  • Coperion GmbH
  • Gericke AG
  • Powerex Corp
  • Freund -Vector Corporation
  • Fette Compacting
  • LEISTRITZ AG
  • KORSCH AG
  • ACG
  • Cadmach Machinery Co. Pvt . Ltd.
  • ALEXANDERWERK AG
  • Hovione
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is pharmaceutical continuous manufacturing?

Continuous Manufacturing technology is a method in which continuous development of products is involved to allow faster manufacturing with more productive and profitable products. The continuous manufacturing method in the pharmaceutical attributes to the production of an active component in a compressed unit with a high degree of automation. The market is driven by less time investment, less production cost, faster availability of reliable products in the market.

What are the driving factors for the pharmaceutical continuous manufacturing marketacross the globe?

The growth of the market is attributed to some key driving factors such as increasing shortage of medicines, and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restraint the growth of the market during the forecast years.

What is the regional analysis in terms of pharmaceutical continuous manufacturing market?

Global pharmaceutical continuous manufacturing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for pharmaceutical continuous manufacturing. The federal government in the US and regulatory authorities are supportive towards transition from batch to continuous manufacturing of drugs and APIs which is leading to increasing number of companies and contract manufacturers adopting the techniques thereby leading to the market growth.The Asia Pacific region is expected to account for the fastest growth in the pharmaceutical continuous manufacturing market. In Japan and South Korea, the market is expected to grow owing to factors such as the large population countries such as China and India, increasing focus of market players towards Asian countries to open new production facilities in these regions, rising number of pharmaceutical companies.

The List of Companies - Pharmaceutical Continuous Manufacturing Market

  1. GEA Group
  2. Coperion GmbH
  3. Gericke AG
  4. Glatt GmbH
  5. Hosokawa Micron Group
  6. Munson Machinery Co. Inc.
  7. Powrex Corp
  8. Thermo Fisher Scientific Inc.
  9. Freund-vector Corporation
  10. Fette Compacting
  11. Alexanderwerk
  12. LEISTRITZ AG
  13. KORSCH AG
  14. ACG
  15. Cadmach Machinery Co. Pvt. Ltd.
  16. Hovioneen Aesica

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports